MedPage Today: Combination treatment promising for certain leukemia patients
UC expert comments on new study
A combination of low-intensity chemotherapy and an antibody-drug conjugate drug showed promise in a phase 2 trial for older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukemia (ALL).
MedPage Today highlighted the study, and patients in the study had a "significant improvement" in their five-year progression-free survival compared to historical data for this patient set, according to the study's authors.
Emily Curran, MD, medical director of the University of Cincinnati Cancer Center Clinical Trials Office and assistant professor of Internal Medicine in UC's College of Medicine, authored a corresponding commentary on the study, published in The Lancet Hematology.
The study "provides impressive results, with survival outcomes that far exceed historic survival data in older adults with acute lymphocytic leukemia," Curran wrote in the commentary.
Read the MedPage Today article.
Featured photo at top: Dr. Emily Curran examines specimens using a microscope in her lab. Photo/Colleen Kelley/UC Marketing + Brand.
Related Stories
LastPass password manager now available for UC staff
May 17, 2024
The University of Cincinnati has partnered with LastPass to provide staff with enhanced password management services. This news article provides more details about the initiative launched on May 1, offering information and resources to help staff set up and use LastPass effectively for improved online security.
Can new rules in Ohio address a pharmacy staffing shortage and improve care?
May 17, 2024
The University of Cincinnati's Michael Hegener joined WVXU's Cincinnati Edition to discuss recent rules released by the Ohio Board of Pharmacy designed to address pharmacy staffing.
UC’s Dean Lawrence J. Johnson, a transformative figure in CECH, celebrates 25 years
May 17, 2024
The University of Cincinnati's College of Education, Criminal Justice, Human Services, and Information Technology Dean Lawrence J. Johnson retires this year after 25 years in the role (and 34 years with the college). In this article we look at his road to academia and journey to a transformative quarter century at UC.